Dimethyl 3-[7-methyl-2-(2-methylphenyl)-1,3-benzoxazol-5-yl]-2,6-dihydro-1,3-oxazine-4,5-dicarboxylate
C23H22N2O6 — CID 168633287
Data last refreshed: (MolForge compound catalog, from PubChem)
About Dimethyl 3-[7-methyl-2-(2-methylphenyl)-1,3-benzoxazol-5-yl]-2,6-dihydro-1,3-oxazine-4,5-dicarboxylate
Dimethyl 3-[7-methyl-2-(2-methylphenyl)-1,3-benzoxazol-5-yl]-2,6-dihydro-1,3-oxazine-4,5-dicarboxylate (PubChem CID 168633287) has the molecular formula C23H22N2O6 and a molecular weight of 422.44 g/mol. Its IUPAC name is dimethyl 3-[7-methyl-2-(2-methylphenyl)-1,3-benzoxazol-5-yl]-2,6-dihydro-1,3-oxazine-4,5-dicarboxylate.
Molecular Properties
| Compound Name | Dimethyl 3-[7-methyl-2-(2-methylphenyl)-1,3-benzoxazol-5-yl]-2,6-dihydro-1,3-oxazine-4,5-dicarboxylate |
|---|---|
| PubChem CID | 168633287 |
| Molecular Formula | C23H22N2O6 |
| Molecular Weight | 422.44 g/mol |
| Exact Mass | 422.15 |
| IUPAC Name | dimethyl 3-[7-methyl-2-(2-methylphenyl)-1,3-benzoxazol-5-yl]-2,6-dihydro-1,3-oxazine-4,5-dicarboxylate |
| SMILES | COC(=O)C1=C(C(=O)OC)N(c2cc(C)c3oc(-c4ccccc4C)nc3c2)COC1 |
| InChI | InChI=1S/C23H22N2O6/c1-13-7-5-6-8-16(13)21-24-18-10-15(9-14(2)20(18)31-21)25-12-30-11-17(22(26)28-3)19(25)23(27)29-4/h5-10H,11-12H2,1-4H3 |
| InChIKey | HPQVZCLXLFEGEK-UHFFFAOYSA-N |
| XLogP | 3.51 |
| TPSA | 91.10 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 422.44 |
| LogP ≤ 5 | 3.51 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 168633287 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.